Jupiter Endovascular
Jupiter Endovascular is a medical device startup developing flexible-to-firm catheters for endovascular procedures, with 58 employees and $21M in Series B funding raised in October 2025. The company's TFX technology aims to improve vascular access by allowing catheters to switch stiffness on demand, addressing a decades-old limitation in interventional procedures.
The growth story
Jupiter Endovascular grew from 2 to 58 employees between 2023 and 2026, raising $21M along the way, most recently a Series B in October 2025.
About
Jupiter makes catheters that can rapidly change from flexible to rigid during vascular procedures. This is designed to give surgeons better control while reducing trauma to blood vessels, potentially simplifying complex interventions.
The company has grown to 58 staff since its 2024 founding and secured $21M in Series B funding in late 2025. Its backers include LB Investment and Sonder Capital, suggesting strong investor interest in novel vascular access solutions.
Founders and leadership
Engineering dominates Jupiter's workforce with 16 employees, reflecting the technical demands of developing electromechanical catheter systems. The leadership team comes from the Bay Area medtech scene but specific executive backgrounds aren't detailed in the available data.
The Jupiter Endovascular org chart
Carl St. Bernard (Chief Executive Officer) leads 19 mapped leaders with 6 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Engineering 20 (+43% YoY), Operations 11 (+175% YoY), Business Development 6 (0% YoY), Quality Assurance 5 (+67% YoY), Product Management 4 (0% YoY), Research 3 (-40% YoY).
Talent flow
Nearly half the analyzed staff (20 of 42 profiles) came from Neptune Medical, a fellow vascular access startup, suggesting targeted recruitment from direct competitors. Other hires came from established device makers like Medtronic and Boston Scientific.
Most common previous employers of Jupiter Endovascular staff: Neptune Medical (20), Medtronic (7), Boston Scientific (5), Cordis (3), Stryker (3), Sirona Medical (2). Former Jupiter Endovascular employees most often moved to Neptune Medical (3), Guardant Health (1), Parallax Medtech Consulting (1), ALPFA Medical (1), Mendaera (1), Synchron (1).
Alumni worth knowing
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Jupiter Endovascular: Medical Devices (33), Research and Development (R&D) (20), Microsoft Office (20), Leadership (20), Product Development (20), Cross-functional Team Leadership (18), SOLIDWORKS (18), Microsoft Excel (17).
Where the team actually sits
Jupiter Endovascular people are concentrated in California, United States (24), San Francisco Bay Area (9), United States (3), New York, United States (1).
Search footprint
Jupiter Endovascular attracts about 46 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 15 ranking keywords and lost 11 in the last period.
Frequently asked
Jupiter Endovascular has 58 employees as of September 2026.
Jupiter Endovascular has raised $21M in total, most recently a Series B round in October 2025.
Carl St. Bernard (Chief Executive Officer) sits at the top of Jupiter Endovascular's reporting structure, with 6 direct reports.
The most common previous employers of current Jupiter Endovascular staff are Neptune Medical (20 people), Medtronic (7 people), Boston Scientific (5 people).
Former Jupiter Endovascular employees most often move to Neptune Medical (3), Guardant Health (1), Parallax Medtech Consulting (1).
Jupiter Endovascular attracts about 46 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Jupiter Endovascular staff are Medical Devices, Research and Development (R&D), Microsoft Office, Leadership, Product Development.
Jupiter Endovascular staff are concentrated in California, United States (24), San Francisco Bay Area (9), United States (3).
Jupiter Endovascular has about 20 people in Engineering, up 43% over the past year, as of September 2026.
Jupiter Endovascular has about 11 people in Operations, up 175% over the past year, as of September 2026.
Computed from 42 current and 15 former Jupiter Endovascular profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.